HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Nygren Selected Research

Drug Therapy (Chemotherapy)

11/2023Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases.
12/2022Evaluation and validation of chemotherapy-specific diarrhoea and histopathology in rats.
11/2020Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy.
5/2019Percutaneous Irreversible Electroporation as First-line Treatment of Locally Advanced Pancreatic Cancer.
1/2017Predictive Value of Ex Vivo Chemosensitivity Assays for Individualized Cancer Chemotherapy: A Meta-Analysis.
9/2016Preclinical activity of melflufen (J1) in ovarian cancer.
12/2015Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
9/2013Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer.
5/2013Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy.
1/2012Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Nygren Research Topics

Disease

61Neoplasms (Cancer)
03/2024 - 01/2002
21Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 06/2003
9Colonic Neoplasms (Colon Cancer)
03/2024 - 12/2011
8Ovarian Neoplasms (Ovarian Cancer)
01/2018 - 08/2007
7Peritoneal Neoplasms
01/2018 - 06/2011
7Carcinoma (Carcinomatosis)
12/2017 - 06/2006
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2011 - 01/2004
4Neoplasm Metastasis (Metastasis)
11/2023 - 12/2013
4Prostatic Neoplasms (Prostate Cancer)
12/2020 - 11/2014
4Leukemia
08/2013 - 12/2003
4Lymphoma (Lymphomas)
01/2003 - 04/2002
3Nausea
01/2019 - 06/2005
3Pseudomyxoma Peritonei
12/2015 - 04/2012
3Hypoxia (Hypoxemia)
06/2015 - 07/2011
3Stomach Neoplasms (Stomach Cancer)
12/2014 - 01/2012
2Fatigue
05/2021 - 01/2019
2Vomiting
01/2019 - 06/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2017 - 08/2007
2Thrombocytopenia (Thrombopenia)
12/2015 - 05/2010
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2010 - 02/2005
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2008 - 10/2004
2Breast Neoplasms (Breast Cancer)
06/2008 - 01/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2007 - 01/2007
1Mucositis
12/2022
1Body Weight (Weight, Body)
12/2022
1Atrophy
12/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Chronic Disease (Chronic Diseases)
05/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2019
1Constipation
01/2019
1Anemia
01/2019

Drug/Important Bio-Agent (IBA)

8Fluorouracil (Carac)FDA LinkGeneric
12/2023 - 07/2005
6Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2023 - 09/2013
6Doxorubicin (Adriamycin)FDA LinkGeneric
12/2022 - 10/2004
5Irinotecan (Camptosar)FDA LinkGeneric
12/2022 - 03/2010
5Melphalan (Alkeran)FDA LinkGeneric
09/2017 - 12/2003
5Docetaxel (Taxotere)FDA Link
12/2014 - 06/2005
5N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA
05/2010 - 04/2002
4Proteins (Proteins, Gene)FDA Link
11/2020 - 04/2012
4IronIBA
09/2019 - 07/2011
4VLX600IBA
09/2019 - 01/2014
4Mebendazole (Anti-Worm)FDA Link
07/2018 - 12/2013
4Cisplatin (Platino)FDA LinkGeneric
12/2015 - 03/2012
3Antineoplastic Agents (Antineoplastics)IBA
03/2024 - 08/2015
3nitazoxanide (NTZ)FDA Link
04/2022 - 06/2015
3EnzymesIBA
11/2020 - 04/2002
3Biomarkers (Surrogate Marker)IBA
07/2018 - 08/2016
3Sirolimus (Rapamycin)FDA Link
01/2018 - 12/2008
3melflufenIBA
09/2017 - 12/2015
3Alkylating AgentsIBA
09/2016 - 06/2008
3Peptide Hydrolases (Proteases)FDA Link
09/2016 - 07/2003
3Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2015 - 09/2013
3AnthelminticsIBA
06/2015 - 12/2013
3Bortezomib (Velcade)FDA Link
12/2014 - 01/2009
3dicyandiamido (cyanoguanidine)IBA
01/2004 - 04/2002
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2024 - 02/2023
2Leucovorin (Folinic Acid)FDA Link
12/2023 - 03/2010
2Bevacizumab (Avastin)FDA Link
12/2023 - 01/2005
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
12/2022 - 06/2002
2Sorafenib (BAY 43-9006)FDA Link
01/2022 - 12/2014
2Phosphotransferases (Kinase)IBA
11/2020 - 01/2018
2Chelating AgentsIBA
01/2019 - 12/2016
2Drug CombinationsIBA
11/2017 - 12/2008
2AminopeptidasesIBA
09/2017 - 12/2015
2CD13 Antigens (Alanine Aminopeptidase)IBA
09/2017 - 03/2011
2UbiquitinIBA
05/2017 - 02/2013
2CD 02750IBA
05/2017 - 07/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
05/2017 - 02/2013
2PlatinumIBA
09/2016 - 12/2015
2ErbB Receptors (EGF Receptor)IBA
08/2016 - 01/2012
2Imatinib Mesylate (Gleevec)FDA Link
08/2015 - 03/2012
2Fluorescein (Funduscein)FDA LinkGeneric
12/2014 - 08/2012
2Quillaja SaponinsIBA
01/2013 - 02/2010
2Tumor Biomarkers (Tumor Markers)IBA
12/2012 - 09/2012
2Etoposide (VP 16)FDA LinkGeneric
06/2008 - 10/2004
2Epirubicin (Ellence)FDA LinkGeneric
01/2007 - 07/2005
2Disulfiram (Antabuse)FDA Link
01/2007 - 03/2006
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2007 - 07/2005
1Simvastatin (Zocor)FDA LinkGeneric
03/2024
1mevastatin (CS 500)IBA
03/2024
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2023
1pitavastatin (itavastatin)FDA Link
02/2023
1Immunomodulating AgentsIBA
02/2023
1CytokinesIBA
02/2023
1Tyrosine Kinase InhibitorsIBA
01/2023
1Green Fluorescent ProteinsIBA
04/2022
1regorafenibIBA
01/2022
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
12/2020
1NucleotidesIBA
11/2020
1Oxygen (Dioxygen)IBA
09/2019
1Hormones (Hormone)IBA
09/2019
1Alkaline PhosphataseIBA
01/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2018
1Biocompatible Materials (Biomaterials)IBA
02/2018
1Protein Kinase InhibitorsIBA
01/2018

Therapy/Procedure

20Drug Therapy (Chemotherapy)
11/2023 - 01/2002
11Therapeutics
05/2021 - 01/2007
9Cytoreduction Surgical Procedures
09/2016 - 06/2011
5Hyperthermic Intraperitoneal Chemotherapy
08/2015 - 06/2011
3Radiotherapy
07/2020 - 11/2014